서울대학교 중앙도서관
S-Space 소개
My S-Space
로그인이 필요합니다.
Login

S-Space

Browse

Subject

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 21 of 21

Issue DateTitle / Author(s) / CitationFileAltmetrics
2006-08
Prediction of residual immunity to smallpox, by means of an intradermal skin test with inactivated vaccinia virus
DOI
2012-01
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
DOI
2012-07
Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in HER2-positive metastatic breast cancer
DOI
2014-05
Effects of reduction in the alpha-gal antigen on bony union: a model of xenobone graft using GalT knockout mouse
DOI
2014-11
Biomarker Analyses in CLEOPATRA: A Phase III, Placebo-Controlled Study of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive, First-Line Metastatic Breast Cancer

Baselga, Jose; Cortes, Javier; Im, Seock-Ah; Clark, Emma; Ross, Graham; Kiermaier, Astrid; Swain, Sandra M.

Journal of Clinical Oncology, Vol.32 No.33, pp.3753-3761

DOI
2017-08
HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
DOI
2019-07
Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
DOI
2019-10
The HER2 S310F Mutant Can Form an Active Heterodimer with the EGFR, Which Can Be Inhibited by Cetuximab but Not by Trastuzumab as well as Pertuzumab
DOI
2019-10
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
DOI
2020-04
A high-throughput single-clone phage fluorescence microwell immunoassay and laser-driven clonal retrieval system
DOI
2020-05
GITR Agonism Triggers Antitumor Immune Responses through IL21-Expressing Follicular Helper T Cells
DOI
2020-10
T-Cell-Mimicking Nanoparticles for Cancer Immunotherapy
DOI
2020-11
Intracellular amyloid-β disrupts tight junctions of the retinal pigment epithelium via NF-κB activation

Jo, Dong Hyun; Cho, Chang Sik; Kim, Jin Hyoung; Kim, Jeong Hun

Neurobiology of Aging, Vol.95, pp.115-122

DOI
2021-01
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
DOI
2021-01
Immunogenicity and safety of a live herpes zoster vaccine in hematopoietic stem cell transplant recipients
DOI
2021-03
Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer
DOI
2021-12
Genetic polymorphism and natural selection of apical membrane antigen-1 in plasmodium falciparum isolates from vietnam
DOI
2022-11
Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy

Huh, Yeon-Ju; Cho, Sung Yup; Cho, Min-Sun; Lee, Kyoung-Eun; Lee, Joo-Ho

Genes & Genomics, Vol.44 No.11, pp.1425-1435

DOI
2023-02
Myeloid cells protect corneal nerves against sterile injury through negative-feedback regulation of TLR2-IL-6 axis

Lee, Hyun Ju; Kim, Hyeon Ji; Ko, Jung Hwa; Oh, Joo Youn

Journal of Neuroinflammation, Vol.20 No.1, p. 12974

DOI
2023-10
ILUSTRO: Phase II Multicohort Trial of Zolbetuximab in Patients with Advanced or Metastatic Claudin 18.2–Positive Gastric or Gastroesophageal Junction Adenocarcinoma
DOI
2024-02
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring <i>NRG1</i> gene fusions
DOI
1